Duration of response and tumor shrinkage with first-line ribociclib plus letrozole in postmenopausal women with HR1, HER2-ABCW. Janni,E. Alba Conejo,T. Bachelot,S. Diab,M. Gil-Gil,T. J. Beck,L. Ryvo,R. Lopez,M. Tsai,F. J. Esteva,M. P. Zamora Aunon,Z. Kral,P. Ward,P. Richards,T. J. Pluard,S. Sutradhar,M. Miller,M. CamponeANNALS OF ONCOLOGY（2017）引用 0|浏览46暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
